Identification of candidate proteomic markers in the serum of medication overuse headache patients: An exploratory study. (September 2020)

• Record Type: Journal Article
• Authors: Pellesi, Lanfranco; Guerzoni, Simona; Baraldi, Carlo; Cainazzo, Maria Michela; Pini, Luigi Alberto; Bellei, Elisa
• Is Part Of: Cephalalgia. Volume 40:Number 10(2020)
• Page Start: 1070
• Page End: 1078
• Publication Date: 2020-09
• Subjects: Biomarker -- proteomics -- MOH -- serum biomarker -- mechanisms -- pathophysiology; Headache -- Periodicals; 616.8491
• DOI: 10.1177/0333102420921847
• Languages: English
• ISSNs: 0333-1024

Abstract

Purpose of the study: The pathophysiological mechanism of medication overuse headache is uncertain; no distinctive markers have been described right now. The aim of this study was to conduct proteomic analyses on serum samples from patients with medication overuse headache and healthy individuals. Specifically, mono- (SDS-PAGE) and two-dimensional gel electrophoresis (2-DE) followed by liquid chromatography tandem mass spectrometry (LC-MS/MS) were used to evaluate changes in serum proteins. Main findings: By SDS-PAGE, four over-expressed bands were revealed in patients, compared to controls. 2-DE combined with LC-MS/MS analysis allowed confirmation of some proteins preliminarily detected by SDS-PAGE: Hemopexin, alpha-1-acid glycoprotein 1, apolipoprotein A4 and haptoglobin. Moreover, other differential proteins were isolated, mostly increased in MOH patients: Alpha-1-antitrypsin, immunoglobulin heavy constant alpha 1, retinol binding protein and transthyretin. Only one protein, immunoglobulin kappa constant, was decreased in the patients' group. Conclusions: The investigation of the serum proteome can offer a better understanding about biological mechanisms underlying medication overuse headache. Specifically, medication overuse headache shares some serum biochemical markers with chronic pain conditions. Further studies might uncover the relevance of these proteins in medication overuse headache.